Skip to main content
Clinical Trials/NL-OMON19904
NL-OMON19904
Not yet recruiting
Not Applicable

Circulating tumour cells by diagnostic leukapheresis mirror primary tumour heterogeneity in non-small cell lung cancer

Sponsor: Innovative Medicine initiativeperformer: UMCG0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
circulating tumour cells (CTC)Non small cell lung carcinoma (NSCLC)Diagnostic leukapheresis (DLA)tumour heterogeneitycirculerende tumor cellen (CTC)niet kleincellig long carcinoom (NSCLC)diagnostische leukopherese (DLA)tumor heterogeniteit
Sponsor
Sponsor: Innovative Medicine initiativeperformer: UMCG
Enrollment
80
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Sponsor: Innovative Medicine initiativeperformer: UMCG

Eligibility Criteria

Inclusion Criteria

  • Patients with a histologically proven pulmonary malignancy (all disease stages)
  • Performance status 0\-2

Exclusion Criteria

  • Patients with insufficient peripheral venes to undergo leukapheresis
  • Haemorrhagic diathesis: recent CVA, major bleeding, ulcus duodeni

Outcomes

Primary Outcomes

Not specified

Similar Trials